2348.HK

Dawnrays Pharmaceutical (Holdings) Limited [2348.HK] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

2348.HK Stock Summary

Earnings have grown 9.66% per last year.

Top 10 Correlated ETFs

2348.HK

Top 10 Correlated Stocks

2348.HK

In the News

2348.HK Financial details

Company Rating

Market Cap

1.8B

Income

805.53M

Revenue

2.48B

Book val./share

Cash/share

Dividend

0.09

Dividend %

7.86%

Employees

1.14K

Optionable

Shortable

Yes

Earnings

22 Mar 2024

P/E

4.3

Forward P/E

PEG

0.36

P/S

1.21

P/B

0.58

P/C

P/FCF

7.38

Quick Ratio

1.07

Current Ratio

1.87

Debt / Equity

LT Debt / Equity

EPS (TTM)

0.53

EPS next Y

EPS next Q

EPS this Y

EPS next Y

EPS next 5Y

EPS last 5Y

4.78%

Revenue last 5Y

6.13%

Revenue Q/Q

-0.65%

EPS Q/Q

41.67%

SMA20

-5.74%

SMA50

-3.36%

SMA100

-5.74%

Inst Own

Inst Trans

ROA

10%

ROE

14%

ROC

0.15%

Gross Margin

61%

Oper. Margin

31%

Profit Margin

28%

Payout

28%

Shs Outstand

Shs Float

Target Price

52W Range

0.98-1.4

52W High

52W Low

RSI

48.84

Rel Volume

0.45

Avg Volume

312.63K

Volume

140K

Perf Week

2.65%

Perf Month

-5.69%

Perf Quarter

-6.45%

Perf Half Y

-7.2%

Beta

0.721

Volatility

0.01%, 0.04%

Prev Close

Price

1.16

Change

2348.HK Financial Performance

2348.HK Dividend History

2348.HK Frequently Asked Questions

What is Dawnrays Pharmaceutical (Holdings) Limited stock symbol ?

Dawnrays Pharmaceutical (Holdings) Limited is a HK stock and trading under the symbol 2348.HK

What is Dawnrays Pharmaceutical (Holdings) Limited stock quote today ?

Dawnrays Pharmaceutical (Holdings) Limited stock price is $1.16 today.

Is Dawnrays Pharmaceutical (Holdings) Limited stock public?

Yes, Dawnrays Pharmaceutical (Holdings) Limited is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 312.63K
Market Capitalization 1.8B
Employee 1.14K
CEO Mr. Weixian Wu
Headquarters Wan Chai,HK
IPO Date 2003-07-11
Website https://www.dawnrays.com

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.